Skip to main content

Advertisement

SpringerLink
Log in

Dysfunctional Voiders—Medication Versus Urotherapy?

  • Pediatric Urology (D Weiss, Section Editor)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Dysfunctional voiding is defined as “habitual contraction of the urethral sphincter during voiding.” Children with dysfunctional voiding remain a challenge, and the approach to and management of LUT dysfunction varies widely among programs and providers with the role of pharmacotherapy being ill defined.

Recent Findings

Animated biofeedback is the current treatment modality of choice in children who are not responsive to standard urotherapy. Comprehensive biofeedback programs incorporate continued elimination education, voiding diaries, and home exercises with high success rates. Recent studies suggest botulinum toxin A results in persistent satisfactory results in select children with refractory dysfunctional voiding.

Summary

Conservative measures including an aggressive bowel regimen and timed voiding are the mainstays of treatment, and motivated children with persistent symptoms often respond favorably to escalating urotherapy with biofeedback. Pharmacotherapy plays an ancillary role in the management of dysfunctional voiding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Neveus T, von Gontard A, Hoebeke P, Hjalmas K, Bauer S, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children’s Continence Society. J Urol. 2006;176:314–24.

    Article  PubMed  Google Scholar 

  2. Hagglof B, Andren O, Bergstrom E, Marklund L, Wendelius M. Self-esteem in children with nocturnal enuresis and urinary incontinence: improvement of self-esteem after treatment. Eur Urol. 1998;33 Suppl 3:16–9.

    PubMed  Google Scholar 

  3. •• Austin PF, Bauer SB, Bower W, Chase J, Franco I, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the Standardization Committee of the International Children’s Continence Society. J Urol. 2014;191:1863–5. The ICCS terminology report provides a current and consensus update to the evolving terminology and understanding of lower urinary tract function in the pediatric population.

  4. Chase J, Austin P, Hoebeke P, McKenna P. The management of dysfunctional voiding in children: a report from the Standardisation Committee of the International Children’s Continence Society. J Urol. 2010;183:1296–302.

    Article  PubMed  Google Scholar 

  5. Burgers RE, Mugie SM, Chase J, Cooper CS, von Gontard A, Rittig CS, et al. Management of functional constipation in children with lower urinary tract symptoms: report from the Standardization Committee of the International Children’s Continence Society. J Urol. 2013;190:29–36.

    Article  PubMed  Google Scholar 

  6. Chen JJ, Mao W, Homayoon K, Steinhardt GF. A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children. J Urol. 2004;171:1907–10.

    Article  PubMed  Google Scholar 

  7. van Gool JD, Hjalmas K, Tamminen-Mobius T, Olbing H. Historical clues to the complex of dysfunctional voiding, urinary tract infection and vesicoureteral reflux. The International Reflux Study in Children. J Urol. 1992;148:1699–702.

    PubMed  Google Scholar 

  8. Hoebeke P. Twenty years of urotherapy in children: what have we learned? Eur Urol. 2006;49:426–8.

    Article  PubMed  Google Scholar 

  9. Franco I. Functional bladder problems in children: pathophysiology, diagnosis, and treatment. Pediatr Clin N Am. 2012;59:783–817.

    Article  Google Scholar 

  10. Belsac AT, Koni A, Bozaci AC, Dogan HS, Tekgul S. Postvoidal residual urine is the most significant non-invasive diagnostic test to predict the treatment outcome in children with non-neurogenic lower urinary tract dysfunction. J Pediatr Urol. 2016;12:215e1–8.

    Article  Google Scholar 

  11. Wenske S, Van Batavia JP, Combs AJ, Glassberg KI. Analysis of uroflow patterns in children with dysfunctional voiding. J Pediatr Urol. 2014;10:250–4.

    Article  PubMed  Google Scholar 

  12. Wenske S, Combs AJ, Van Batavia JP, Glassberg KI. Can staccato and interrupted/fractionated uroflow patterns alone correctly identify the underlying lower urinary tract condition? J Urol. 2012;187:188–93.

    Article  Google Scholar 

  13. Bael A, Lax H, de Jong TP, Hoebeke P, Nijman RJ, Sixt J, et al. The relevance of urodynamic studies for urge syndrome and dysfunctional voiding: a multicenter controlled trial in children. J Urol. 2008;180:1486–93.

    Article  PubMed  Google Scholar 

  14. Afzal NA, Tighe MP, Thomson MA. Constipation in children. Ital J Pediatr. 2011;13:37.

    Google Scholar 

  15. Burgers R, de Jong TP, Visser M, Di Lorenzo C, Dijkgraaf MG, Benning M. Functional defecation disorders in children with lower urinary tract symptoms. J Urol. 2013;189:1886–91.

    Article  PubMed  Google Scholar 

  16. de Jong T, Klijn AJ, Vijverberg MA, de Kort LM, van Empelen R, et al. Effect of biofeedback training on paradoxical pelvic floor movement in children with dysfunctional voiding. Urology. 2007;70:790–3.

    Article  PubMed  Google Scholar 

  17. Franco I. The central nervous system and its role in bowel and bladder control. Curr Urol Rep. 2011;12:153–7.

    Article  PubMed  Google Scholar 

  18. Erickson BA, Austin JC, Cooper CS, Boyt MA. Polyethylene glycol 3350 for constipation in children with dysfunctional elimination. J Urol. 2003;170:1518–20.

    Article  CAS  PubMed  Google Scholar 

  19. Loening-Bauke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. 1997;100:228–32.

    Article  Google Scholar 

  20. Dohil R, Roberts E, Jones KV, Jenkins HR. Constipation and reversible urinary tract abnormalities. Arch Dis Child. 1994;70:56–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Borch L, Hagstroem S, Bower WF, Siggaard Rittig C, Rittig S. Bladder and bowel dysfunction and the resolution of urinary incontinence with successful management of bowel symptoms in children. Acta Paediatr. 2013;102:e215–20.

    Article  PubMed  Google Scholar 

  22. Wolfe-Christensen C, Manolis A, Guy WC, Kovacevic N, Zoubi N, El-Baba M, et al. Bladder and bowel dysfunction: evidence for multidisciplinary care. J Urol. 2013;190:1864–8.

    Article  PubMed  Google Scholar 

  23. Palmer LS. Evaluation and targeted therapy of voiding dysfunction in children. Urology. 2016;92:87–94.

    Article  PubMed  Google Scholar 

  24. Mugie SM, Di Lorenzo C, Benninga MA. Constipation in childhood. Nat Rev Gastroenterol Hepatol. 2011;8:502–11.

    Article  PubMed  Google Scholar 

  25. Wennergren HM, Oberg BE, Sandstedt P. The importance of leg support for relaxation of the pelvic floor muscles. A surface electromyograph study in healthy girls. Scand J Urol Nephrol. 1991;25:205–13.

    Article  CAS  PubMed  Google Scholar 

  26. Maternik M, Krzeminska K, Zurowska A. The management of childhood urinary incontinence. Pediatr Nephrol. 2015;30:41–50.

    Article  PubMed  Google Scholar 

  27. Allen HA, Austin JC, Boyt MA, Hawtrey CE, Cooper CS. Initial trial of timed voiding is warranted for all children with daytime incontinence. Urology. 2007;69:962–5.

    Article  PubMed  Google Scholar 

  28. Hagstroem S, Rittig S, Kamperis K, Djurhuus JC. Timer watch assisted urotherapy in children: a randomized controlled trial. J Urol. 2010;184:1482–8.

    Article  PubMed  Google Scholar 

  29. Thom M, Campigotto M, Vemulakonda V, Coplen D, Austin PF. Management of lower urinary tract dysfunction: a stepwise approach. J Pediatr Urol. 2012;8:20–4.

    Article  PubMed  Google Scholar 

  30. • Braga LH, Rickard M, Farrokhyar F, Jegatheeswaran K, Brownrigg N, Li C, et al. Bladder training video versus standard urotherapy for bladder and bowel dysfunction: a non-inferiority randomized controlled trial. J Urol 2016. Randomized, controlled trial demonstrating that a bladder training video was as effective as standard urotherapy via individualized instruction in children aged 5–10 years with bladder-bowel dysfunction.

  31. Feldman AS, Bauer SB. Diagnosis and management of dysfunctional voiding. Curr Opin Pediatr. 2006;18:139–47.

    Article  PubMed  Google Scholar 

  32. McKenna PH, Herndon CD, Connery S, Ferrer FA. Pelvic floor muscle retraining for pediatric voiding dysfunction using interactive computer games. J Urol. 1999;162:1056–62.

    Article  CAS  PubMed  Google Scholar 

  33. Kaye JD, Palmer LS. Animated biofeedback yields more rapid results than nonanimated biofeedback in the treatment of dysfunctional voiding in girls. J Urol. 2008;180:300–5.

    Article  PubMed  Google Scholar 

  34. Bower WF, Yew SY, Sit KY, Yeung CK. Half-day urotherapy improves voiding parameters in children with dysfunctional emptying. Eur Urol. 2006;49:570–4.

    Article  PubMed  Google Scholar 

  35. Herndon CD, Decambre M, McKenna PH. Interactive computer games for treatment of pelvic floor dysfunction. J Urol. 2001;166:1893–8.

    Article  CAS  PubMed  Google Scholar 

  36. Hoebeke P, Vande Walle J, Theunis M, De Paepe H, Oosterlinck W, Renson C. Outpatient pelvic-floor therapy in girls with daytime incontinence and dysfunctional voiding. Urology. 1996;48:923–7.

    Article  CAS  PubMed  Google Scholar 

  37. Heilenkötter K, Bachmann C, Janhsen E, Stauber T, Lax H, Petermann F, et al. Prospective evaluation of inpatient and outpatient bladder training in children with functional urinary incontinence. Urology. 2006;67:176–80.

    Article  PubMed  Google Scholar 

  38. Brownrigg N, Pemberton J, Jegatheeswaran K, DeMaria J, Braga LH. A pilot randomized controlled trial evaluating the effectiveness of group vs individual urotherapy in decreasing symptoms associated with bladder-bowel dysfunction. J Urol. 2015;193:1347–52.

    Article  PubMed  Google Scholar 

  39. Mulders MM, Cobussen-Boekhorst H, de Gier RP, Feitz WF, Kortmann BB. Urotherapy in children: quantitative measurements of daytime urinary incontinence before and after treatment according to the new definitions of the International Children’s Continence Society. J Pediatr Urol. 2011;7:213–8.

    Article  CAS  PubMed  Google Scholar 

  40. Bachmann CJ, Heilenkötter K, Janhsen E, Ackmann C, Thomä M, Lax H, et al. Long-term effects of a urotherapy training program in children with functional urinary incontinence: a 2-year follow-up. Scand J Urol Nephrol. 2008;42:337–43.

    Article  PubMed  Google Scholar 

  41. Kajbafzadeh AM, Sharifi-Rad L, Ghahestani SM, Ahmadi H, Kajbafzadeh M. Animated biofeedback: an ideal treatment for children with dysfunctional elimination syndrome. J Urol. 2011;186:2379–84.

    Article  PubMed  Google Scholar 

  42. Tugtepe H, Thomas DT, Ergun R, Abdullayev T, Kastarli C, Kaynak A, et al. Comparison of biofeedback therapy in children with treatment-refractory dysfunctional voiding and overactive bladder. Urology. 2015;85:900–4.

    Article  PubMed  Google Scholar 

  43. Barroso U, Tourinho R, Lordêlo P, Hoebeke P, Chase J. Electrical stimulation for lower urinary tract dysfunction in children: a systematic review of the literature. Neurourol Urodyn. 2011;30:1429–36.

    Article  PubMed  Google Scholar 

  44. Lyon RP, Tanagho EA. Distal urethral stenosis in little girls. J Urol. 1965;93:379–88.

    CAS  PubMed  Google Scholar 

  45. Metwalli AR, Cheng EY, Kropp BP, Pope JC. The practice of urethral dilation for voiding dysfunction among fellows of the section on urology of the American Academy of Pediatrics. J Urol. 2002;168:1764–7.

    Article  PubMed  Google Scholar 

  46. von Gontard A, Baeyens D, Van Hoecke E, Warzak WJ, Bachmann C. Psychological and psychiatric issues in urinary and fecal incontinence. J Urol. 2011;185:1432–6.

    Article  Google Scholar 

  47. Wolfe-Christensen C, Veenstra AL, Kovacevic L, Elder JS, Lakshmanan Y. Psychosocial difficulties in children referred to pediatric urology: a closer look. Urology. 2012;80:907–13.

    Article  PubMed  Google Scholar 

  48. Bauer SB, Austin PF, Rawashdeh YF, de Jong TP, Franco I, Siggard C, et al. International Children’s Continence Society’s recommendations for initial diagnostic evaluation and follow-up in congenital neuropathic bladder and bowel dysfunction in children. Neurourol Urodyn. 2012;31:610–4.

    Article  PubMed  Google Scholar 

  49. Yucel S, Akkaya E, Guntekin E, Kukul E, Akman S, Melikoglu M, et al. Can alpha-blocker therapy be an alternative to biofeedback for dysfunctional voiding and urinary retention? A prospective study. J Urol. 2005;174:1612–5.

    Article  CAS  PubMed  Google Scholar 

  50. Van Batavia JP, Combs AJ, Horowitz M, Glassberg KI. Primary bladder neck dysfunction in children and adolescents III: results of long-term alpha-blocker therapy. J Urol. 2010;183:724–30.

    Article  PubMed  Google Scholar 

  51. Cain MP, Wu SD, Austin PF, Herndon CD, Rink RC. Alpha blocker therapy for children with dysfunctional voiding and urinary retention. J Urol. 2003;170:1514–5.

    Article  CAS  PubMed  Google Scholar 

  52. Vanderbrink BA, Gitlin J, Toro S, Palmer LS. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children. J Urol. 2009;181:817–22.

    Article  CAS  PubMed  Google Scholar 

  53. Kramer SA, Rathbun SR, Elkins D, Karnes RJ, Husmann DA. Double-blind placebo controlled study of alpha-adrenergic receptor antagonists (doxazosin) for treatment of voiding dysfunction in the pediatric population. J Urol. 2005;173:2121–4.

    Article  CAS  PubMed  Google Scholar 

  54. Radojicic ZI, Perovic SV, Milic NM. Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin? J Urol. 2006;176:332–6.

    Article  PubMed  Google Scholar 

  55. Mokhless I, Gaafar S, Fouda K, Shafik M, Assem A. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder. J Urol. 2006;176:1767–70.

    Article  CAS  PubMed  Google Scholar 

  56. Steinhardt GF, Naseer S, Cruz OA. Botulinum toxin: novel treatment for dramatic urethral dilatation associated with dysfunctional voiding. J Urol. 1997;158:190–1.

    Article  CAS  PubMed  Google Scholar 

  57. ‘t Hoen LA, van den Hoek J, Wolffenbuttel KP, van der Toorn F, Scheepe JR. Breaking the vicious circle: onabotulinum toxin A in children with therapy-refractory dysfunctional voiding. J Pediatr Urol. 2015;11:119e1–6.

    Article  Google Scholar 

  58. • Vricella GJ, Campigotto M, Coplen DE, Traxel EJ, Austin PF. Long-term efficacy and durability of botulinum-A toxin for refractory dysfunctional voiding in children. J Urol. 2014;191:1586–91. Review of 12 children with refractory dysfunctional voiding who failed urotherapy and medical management; at a mean follow-up of 45 months, 67% of children experienced significant symptom improvement.

  59. Youdim K, Kogan BA. Preliminary study of the safety and efficacy of extended-release oxybutynin in children. Urology. 2002;59:428–32.

    Article  PubMed  Google Scholar 

  60. Reinberg Y, Crocker J, Wolpert J, Vandersteen D. Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence. J Urol. 2003;169:317–9.

    Article  CAS  PubMed  Google Scholar 

  61. Lopez Pereira P, Miguelez C, Caffarati J, Estornell F, Anguera A. Trospium chloride for the treatment of detrusor instability in children. J Urol. 2003;170:1978–81.

    Article  CAS  PubMed  Google Scholar 

  62. Nijman RJ. Role of antimuscarinics in the treatment of nonneurogenic daytime urinary incontinence in children. Urology. 2004;63:45–50.

    Article  PubMed  Google Scholar 

  63. Nadeau G, Schröder A, Moore K, Genois L, Lamontagne P, Hamel M, et al. Long-term use of solifenacin in pediatric patients with overactive bladder: extension of a prospective open-label study. Can Urol Assoc J. 2014;8:118–23.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Malhotra B, El-Tahtawy A, Wang EQ, Darekar A, Cossons N, Crook TJ. Dose-escalating study of the pharmacokinetics and tolerability of fesoterodine in children with overactive bladder. J Pediatr Urol. 2012;8:336–42.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, 3RCP, Iowa City, IA, 52242-1089, USA

    Angela M. Arlen

  2. Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

    Angela M. Arlen

Authors
  1. Angela M. Arlen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angela M. Arlen.

Ethics declarations

Conflict of Interest

Angela M. Arlen declares no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Pediatric Urology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arlen, A.M. Dysfunctional Voiders—Medication Versus Urotherapy?. Curr Urol Rep 18, 14 (2017). https://doi.org/10.1007/s11934-017-0656-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-017-0656-0

Keywords

Search

Navigation